Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07305402

Vascular Infections Caused by Coxiella Burnetii

A French Multicenter Retrospective Study of Native and Prosthetic Vascular Infections Caused by Coxiella Burnetii (COXIVAS)

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
University Hospital, Bordeaux · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

high morbidity and mortality. In France, Coxiella burnetii-related vascular infections appear to be increasing, though data remain limited. Two-year mortality reaches 15-18%, mainly due to serious complications such as arterio-digestive fistulas. Diagnosis is often delayed, prognostic factors are poorly defined, and the value of advanced imaging techniques remains insufficiently studied.

Detailed description

Q fever is a worldwide zoonosis that may cause chronic vascular infections with significant morbidity and mortality. In France, the incidence of Coxiella burnetii-related vascular infections appears to be increasing, although published data remain scarce. Reported two-year mortality reaches 15-18%, largely due to severe complications such as arterio-digestive fistulas. Classical risk factors include aortic aneurysm and vascular grafts, but many patients present without clear zoonotic exposure, leading to frequent underdiagnosis. Prognostic factors are poorly defined, apart from the lack of surgical management, which worsens outcomes. Diagnosis is often delayed, and the value of advanced imaging modalities such as 18F-FDG PET/CT or labeled leukocyte scintigraphy remains insufficiently studied.

Conditions

Timeline

Start date
2026-01-01
Primary completion
2026-05-01
Completion
2026-05-01
First posted
2025-12-26
Last updated
2025-12-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07305402. Inclusion in this directory is not an endorsement.